Filings/ASMB/IR

ASSEMBLY BIOSCIENCES, INC. IR

press release · 2025

Safety, Pharmacokinetics, and Antiviral Activity of the Next-Generation Hepatitis B CAM ABI-4334 in Patients With HBeAg-Negative Chronic Hepatitis B Infection Not Suppressed on Nucleoside Analogues: Results From a Randomized, Blinded, Phase 1b Study

Source document

Issuer site
Loading document…
Safety, Pharmacokinetics, and Antiviral Activity of the Next-Generation Hepatitis B CAM ABI-4334 in Patients With HBeAg-Negative Chronic Hepatitis B Infection Not Suppressed on Nucleoside Analogues: Results From a Randomized, Blinded, Phase 1b Study — ASSEMBLY BIOSCIENCES, INC.